Literature DB >> 29808445

Assessing Disparities in the Rates of HCV Diagnoses Within American Indian or Alaska Native Populations Served by the U.S. Indian Health Service, 2005-2015.

Brigg Reilley1, Jessica Leston2, Mona Doshani3, Dana L Haberling4, Marissa Person4, Thomas Weiser5, Melissa Collier3, Jonathan Iralu6, Jorge Mera7, Rick Haverkate8.   

Abstract

Hepatitis C virus (HCV) disproportionately affects American Indians/Alaska Natives (AI/AN). The Indian Health Service (IHS), via federal and tribal health facilities provides medical services to an estimated 2.2 million AI/AN people in the United States. HCV diagnoses, defined by International Classification of Diseases 9th Revision, Clinical Modification (ICD-9-CM) codes, were analyzed from 2005 to 2015. Results showed 29,803 patients with an HCV diagnosis; 53.4% were among persons born 1945-1965 and overall HCV burden was higher among males than females. These data will help inform local, regional, and national efforts to address, plan for and carry out a national strategy to provide treatment for HCV infected patients and programs to prevent new HCV infections.

Entities:  

Keywords:  American Indian Alaskan Native; Hepatitis C virus; Indian Health Service

Mesh:

Substances:

Year:  2018        PMID: 29808445     DOI: 10.1007/s10900-018-0528-7

Source DB:  PubMed          Journal:  J Community Health        ISSN: 0094-5145


  10 in total

1.  Simple, Effective, but Out of Reach? Public Health Implications of HCV Drugs.

Authors:  John W Ward; Jonathan H Mermin
Journal:  N Engl J Med       Date:  2015-11-17       Impact factor: 91.245

2.  Survival of patients with HCV cirrhosis and sustained virologic response is similar to the general population.

Authors:  Savino Bruno; Vito Di Marco; Massimo Iavarone; Luigi Roffi; Andrea Crosignani; Vincenza Calvaruso; Alessio Aghemo; Giuseppe Cabibbo; Mauro Viganò; Vincenzo Boccaccio; Antonio Craxí; Massimo Colombo; Patrick Maisonneuve
Journal:  J Hepatol       Date:  2016-04-05       Impact factor: 25.083

3.  Toward a more accurate estimate of the prevalence of hepatitis C in the United States.

Authors:  Brian R Edlin; Benjamin J Eckhardt; Marla A Shu; Scott D Holmberg; Tracy Swan
Journal:  Hepatology       Date:  2015-08-25       Impact factor: 17.425

4.  Transformation of hepatitis C antiviral treatment in a national healthcare system following the introduction of direct antiviral agents.

Authors:  A M Moon; P K Green; K Berry; G N Ioannou
Journal:  Aliment Pharmacol Ther       Date:  2017-03-08       Impact factor: 8.171

5.  Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965.

Authors:  Bryce D Smith; Rebecca L Morgan; Geoff A Beckett; Yngve Falck-Ytter; Deborah Holtzman; Chong-Gee Teo; Amy Jewett; Brittney Baack; David B Rein; Nita Patel; Miriam Alter; Anthony Yartel; John W Ward
Journal:  MMWR Recomm Rep       Date:  2012-08-17

6.  Birth Cohort Testing for Hepatitis C Virus - Indian Health Service 2012-2015.

Authors:  Brigg Reilley; Jessica Leston; Susan Hariri; Lisa Neel; Miles Rudd; Megan Galope; John Ward; Claudia Vellozzi
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-05-13       Impact factor: 17.586

7.  Infection With Hepatitis C Virus Genotype 3 Is an Independent Risk Factor for End-Stage Liver Disease, Hepatocellular Carcinoma, and Liver-Related Death.

Authors:  Brian J McMahon; Dana Bruden; Lisa Townshend-Bulson; Brenna Simons; Phillip Spradling; Stephen Livingston; James Gove; Annette Hewitt; Julia Plotnik; Chriss Homan; Hannah Espera; Susan Negus; Mary Snowball; Youssef Barbour; Michael Bruce; Prabhu Gounder
Journal:  Clin Gastroenterol Hepatol       Date:  2016-10-17       Impact factor: 11.382

8.  Prevalence of cirrhosis in hepatitis C patients in the Chronic Hepatitis Cohort Study (CHeCS): a retrospective and prospective observational study.

Authors:  Stuart C Gordon; Lois E Lamerato; Loralee B Rupp; Scott D Holmberg; Anne C Moorman; Philip R Spradling; Eyasu Teshale; Fujie Xu; Joseph A Boscarino; Vinutha Vijayadeva; Mark A Schmidt; Nancy Oja-Tebbe; Mei Lu
Journal:  Am J Gastroenterol       Date:  2015-07-28       Impact factor: 10.864

9.  Rising Mortality Associated With Hepatitis C Virus in the United States, 2003-2013.

Authors:  Kathleen N Ly; Elizabeth M Hughes; Ruth B Jiles; Scott D Holmberg
Journal:  Clin Infect Dis       Date:  2016-03-01       Impact factor: 9.079

10.  Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis.

Authors:  Adriaan J van der Meer; Bart J Veldt; Jordan J Feld; Heiner Wedemeyer; Jean-François Dufour; Frank Lammert; Andres Duarte-Rojo; E Jenny Heathcote; Michael P Manns; Lorenz Kuske; Stefan Zeuzem; W Peter Hofmann; Robert J de Knegt; Bettina E Hansen; Harry L A Janssen
Journal:  JAMA       Date:  2012-12-26       Impact factor: 56.272

  10 in total
  1 in total

1.  Hepatitis C drug prescriptions and Medicaid policies--four states, Indian health care system, USA 2018.

Authors:  Brigg Reilley; Matt Miller; Matt Hudson; Rick Haverkate; Jessica Leston
Journal:  Int J Equity Health       Date:  2019-12-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.